<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8912860</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1403</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Reprod Immunol</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Reprod. Immunol.</journal-id>
<journal-title-group>
<journal-title>American journal of reproductive immunology (New York, N.Y. : 1989)</journal-title>
</journal-title-group>
<issn pub-type="ppub">1046-7408</issn>
<issn pub-type="epub">1600-0897</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29271527</article-id>
<article-id pub-id-type="pmc">5966827</article-id>
<article-id pub-id-type="doi">10.1111/aji.12803</article-id>
<article-id pub-id-type="manuscript">NIHMS967297</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Chorioamnionitis, IL-17A, and Fetal Origins of Neurologic Disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lawrence</surname>
<given-names>Shelley M.</given-names>
</name>
<degrees>MD, MS</degrees>
<xref ref-type="author-notes" rid="FN1">†</xref>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wynn</surname>
<given-names>James L.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>University of California, San Diego, College of Medicine, Department of Pediatrics, Division of Neonatal-Perinatal Medicine</aff>
<aff id="A2">
<label>2</label>University of California, San Diego, Department of Pediatrics, Division of Host-Microbe Systems and Therapeutics</aff>
<aff id="A3">
<label>3</label>University of Florida, College of Medicine, Department of Pediatrics, Division of Neonatal-Perinatal Medicine</aff>
<aff id="A4">
<label>4</label>University of Florida, Department of Pathology, Immunology, and Laboratory Medicine</aff>
<author-notes>
<corresp id="FN1"><label>†</label><bold>Corresponding Author:</bold> Shelley M. Lawrence MD, MS. Division of Perinatal-Neonatal Medicine, Department of Pediatrics, The University of California, San Diego; 9500 Gilman Drive, MC0760, La Jolla, California 92093-0760; <email>slawrence@ucsd.edu</email>. Phone: (303) 704-8908; Fax: (858) 822-3593</corresp>
<fn id="FN2">
<p id="P1">James L. Wynn, MD. Division of Perinatal-Neonatal Medicine, Department of Pediatrics, The University of Florida; 1600 SW Archer Rd, P.O. Box 100296, Gainesville, Florida 32610-0296; <email>james.wynn@peds.ufl.edu</email>. Phone: (352) 273-8985</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>14</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>22</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>79</volume>
<issue>5</issue>
<fpage>e12803</fpage>
<lpage>e12803</lpage>
<!--elocation-id from pubmed: 10.1111/aji.12803-->
<abstract>
<p id="P2">The Centers for Disease Control and Prevention estimate that 1 in 323 infants have cerebral palsy. Highly correlated to intrauterine infection and inflammation, the incidence of cerebral palsy has remained constant over the last few decades despite significant advances in neonatal intensive care including improved ventilator techniques, surfactant therapy, maternal steroid administration, and use of intrapartum empiric antimicrobials. Recent advances in our understanding of immune responses to infection and inflammation have identified the cytokine IL-17A as a crucial component of early pro-inflammatory mediators that cause brain injury associated with neurologic impairment. Remarkably, maternal inflammatory responses to <italic>in utero</italic> inflammation and infection can also lead to potentially debilitating neurologic conditions in the offspring, which often become clinically apparent during childhood and/or early adulthood. This review details the role of IL-17A in fetal and maternal proinflammatory responses that lead to fetal brain injury and neurologic sequelae, including cerebral palsy. Recent findings regarding the role of maternal inflammatory responses in the development of childhood and adult neurologic conditions, such as autism, schizophrenia, and multiple sclerosis, will also be highlighted.</p>
</abstract>
<kwd-group>
<kwd>Chorioamnionitis</kwd>
<kwd>IL-17A</kwd>
<kwd>Neonates</kwd>
<kwd>Cerebral palsy</kwd>
<kwd>PVL</kwd>
<kwd>Autism</kwd>
<kwd>Schizophrenia</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>